S. 4987

S. 4987: A bill to require the Federal Trade Commission to submit a report on foreign investment in the pharmaceutical industry of the United States, and for other purposes.

Introduced Elizabeth Warren (D) SENATE_BILL — 119th Congress
Plain English Summary

S. 4987 is a bill that mandates the Federal Trade Commission (FTC) to prepare and submit a report analyzing foreign investments in the U.S. pharmaceutical sector. The report is expected to examine the implications of such investments on the industry, including potential impacts on pricing, innovation, and national security.

Positive Media Summary

Some media outlets have praised S. 4987 for its proactive approach to monitoring foreign investment in the pharmaceutical industry. Supporters argue that the bill will help ensure transparency and protect U.S. interests, particularly in light of growing concerns about foreign influence in critical sectors.

Negative Media Summary

Critics of S. 4987 have expressed concerns that the bill could lead to unnecessary regulatory burdens on foreign investors, potentially stifling innovation and collaboration in the pharmaceutical industry. Some argue that it may create an atmosphere of suspicion towards foreign partnerships, which are essential for global health advancements.

Conflict of Interest Analysis Deep Analysis
2/10
Risk Level
Low
Total Donations
$0
PAC Percentage
0%
Policy Area
Health

The analysis of bill S. 4987, which focuses on foreign investment in the pharmaceutical industry, reveals no direct overlaps between the sponsor Elizabeth Warren's top donor industries and the bill's subject matter. The top donor industries do not include pharmaceutical companies or related sectors, indicating a low risk of conflicts of interest. The lobbying activity in this area, while notable, does not appear to directly influence the sponsor's financial backers, as the largest contributor, CORMEDIX INC., is not among Warren's top donors. This suggests that the motivations behind the bill are not financially compromised by the interests of her donors.

Lobbying Activity — Who's Pushing?

Organizations that lobbied on issues related to this bill's policy area.

Client Lobbying Firm Amount
CORMEDIX INC. CORMEDIX INC. $220,000
BATTELLE MEMORIAL INSTITUTE BATTELLE MEMORIAL INSTITUTE $180,000
TELECOMMUNICATIONS INDUSTRY ASSOCIATION TELECOMMUNICATIONS INDUSTRY ASSOCIATION $70,000
TERRANOVA INC FRONTERA GROUP $30,000
POSEIDON AEROSPACE FRONTERA GROUP $30,000
OBSIDIA SEMICONDUCTORS FRONTERA GROUP $20,000
SAALEX CORPORATION FRONTERA GROUP $20,000
HERTHA METALS FRONTERA GROUP $15,000
MN8 ENERGY LLC MN8 ENERGY LLC $15,000
AMERICAN LIBRARY ASSOCIATION A LEARNED HAND, LLC $10,860
RISK AND INSURANCE MANAGEMENT SOCIETY MCINTYRE & LEMON, PLLC $10,000
VERMONT CAPTIVE INSURANCE ASSOCIATION MCINTYRE & LEMON, PLLC $8,000
AMERICAN TRAILER MANUFACTURERS COALITION WILEY REIN LLP undisclosed
UNCAC COALITION UNCAC COALITION undisclosed
CFA INSTITUTE CFA INSTITUTE undisclosed

Source: Senate Lobbying Disclosure Act (LDA) filings, 2026

Sponsor's Top Donor Industries

Top industries funding Elizabeth Warren, ranked by total contributions.

Health Professionals $120,000,000
Individuals: $120,000,000 PACs: $0
Retired $37,500,000
Individuals: $37,500,000 PACs: $0

Source: OpenSecrets.org (Center for Responsive Politics)

TheBillRoom is free and independent. No ads, no subscriptions, no political funding. If this analysis was useful, reader support keeps it running.
Support Us